- Home
- BTCT vs OSRH Comparison
BTCT vs OSRH Comparison
Compare BTCT & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTCT | OSRH |
|---|---|---|
| Founded | 2006 | N/A |
| Country | Singapore | United States |
| Employees | 21 | 21 |
| Industry | Other Consumer Services | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7M | 11.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BTCT | OSRH |
|---|---|---|
| Price | $1.20 | $0.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 71.5K | ★ 781.5K |
| Earning Date | 05-29-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.30 |
| Revenue Next Year | $283.35 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.07 | $0.38 |
| 52 Week High | $4.72 | $1.79 |
Technical Indicators
Market Signals| Indicator | BTCT | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 46.15 | 42.09 |
| Support Level | $1.09 | $0.44 |
| Resistance Level | $1.23 | $0.63 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 34.48 | 11.96 |
Price Performance
Historical ComparisonAbout BTCT BTC Digital Ltd.
BTC Digital Ltd is a crypto asset technology company based in the U.S. with a focus on bitcoin mining. The company also generates revenue through mining machine resale and rental business operations. Geographically, the financial assets of the company is located in the United States, Singapore, Hong Kong and the PRC.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.